ghk-cu subcutaneous Shop Peptides GHK-Cu Peptide Therapy: The Definitive

Reconstituted solution exposed to room temperature for more than a few hours, or to direct heat or freeze-thaw cycles, should be discarded

Kennedy & Madonna, LLP

Relative Contraindications Active or recent malignancy Pregnancy or breastfeeding (no safety data) Active systemic infection Uncontrolled autoimmune disease in acute flare Concurrent use of anticoagulants without physician oversight Regulatory Status and Where to Source BPC-157 FDA Status (as of 2025) BPC-157 is not FDA-approved for any human therapeutic indication

Start with one peptide at a time, adding each new compound after at least one to two weeks of stable response to the previous one